The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kripaliben Mayank Thakker
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Mrs. Kripaliben Mayank Thakker acquired 18,000 equity shares of Aptus Pharma Ltd on 11.05.2026 through off-market inter-se transfer among the promoter group. The acquisition increased her holding from 5,75,000 shares (8.38%) to 5,93,000 shares (8.64%) of the company's total equity capital of 68,60,000 shares. The mode of acquisition is listed as 'inter-se transfer among Promoter Group'. No pledges, warrants, or convertible securities were involved in this transaction.
A promoter increasing their stake is generally seen as a positive signal for retail investors, indicating promoter confidence in the company's prospects. However, the increase is marginal (0.26%) and the overall holding remains small at 8.64%, so any market impact is likely to be limited and neutral.